nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—ABCB11—Rosuvastatin—atherosclerosis	0.109	0.157	CbGbCtD
Vinblastine—ABCB11—Pravastatin—atherosclerosis	0.0994	0.143	CbGbCtD
Vinblastine—ABCC1—Rosuvastatin—atherosclerosis	0.0776	0.112	CbGbCtD
Vinblastine—ABCC2—Ezetimibe—atherosclerosis	0.0574	0.0827	CbGbCtD
Vinblastine—ABCC2—Simvastatin—atherosclerosis	0.0534	0.0769	CbGbCtD
Vinblastine—ABCC2—Pravastatin—atherosclerosis	0.0522	0.0753	CbGbCtD
Vinblastine—ABCC2—Lovastatin—atherosclerosis	0.0522	0.0753	CbGbCtD
Vinblastine—CYP2D6—Niacin—atherosclerosis	0.0207	0.0299	CbGbCtD
Vinblastine—ABCB1—Ezetimibe—atherosclerosis	0.0187	0.027	CbGbCtD
Vinblastine—ABCB1—Simvastatin—atherosclerosis	0.0174	0.0251	CbGbCtD
Vinblastine—ABCB1—Lovastatin—atherosclerosis	0.017	0.0245	CbGbCtD
Vinblastine—ABCB1—Pravastatin—atherosclerosis	0.017	0.0245	CbGbCtD
Vinblastine—CYP2D6—Simvastatin—atherosclerosis	0.0164	0.0236	CbGbCtD
Vinblastine—CYP2D6—Pravastatin—atherosclerosis	0.016	0.0231	CbGbCtD
Vinblastine—CYP2D6—Lovastatin—atherosclerosis	0.016	0.0231	CbGbCtD
Vinblastine—CYP3A4—Ezetimibe—atherosclerosis	0.0112	0.0162	CbGbCtD
Vinblastine—CYP3A4—Rosuvastatin—atherosclerosis	0.0112	0.0162	CbGbCtD
Vinblastine—CYP3A4—Simvastatin—atherosclerosis	0.0104	0.015	CbGbCtD
Vinblastine—CYP3A4—Pravastatin—atherosclerosis	0.0102	0.0147	CbGbCtD
Vinblastine—CYP3A4—Lovastatin—atherosclerosis	0.0102	0.0147	CbGbCtD
Vinblastine—JUN—artery—atherosclerosis	0.00324	0.0633	CbGeAlD
Vinblastine—JUN—endothelium—atherosclerosis	0.00274	0.0534	CbGeAlD
Vinblastine—JUN—blood vessel—atherosclerosis	0.00252	0.0493	CbGeAlD
Vinblastine—Peptic ulcer—Niacin—atherosclerosis	0.00246	0.0266	CcSEcCtD
Vinblastine—TUBD1—adipose tissue—atherosclerosis	0.00206	0.0403	CbGeAlD
Vinblastine—Numbness—Pravastatin—atherosclerosis	0.00195	0.0211	CcSEcCtD
Vinblastine—TUBE1—adipose tissue—atherosclerosis	0.00193	0.0378	CbGeAlD
Vinblastine—Sensory loss—Pravastatin—atherosclerosis	0.00187	0.0202	CcSEcCtD
Vinblastine—TUBB3—connective tissue—atherosclerosis	0.00183	0.0358	CbGeAlD
Vinblastine—TUBG1—adipose tissue—atherosclerosis	0.00173	0.0338	CbGeAlD
Vinblastine—ABCC6—connective tissue—atherosclerosis	0.00154	0.0302	CbGeAlD
Vinblastine—TUBD1—liver—atherosclerosis	0.00145	0.0283	CbGeAlD
Vinblastine—TUBB1—adipose tissue—atherosclerosis	0.00138	0.0269	CbGeAlD
Vinblastine—TUBE1—liver—atherosclerosis	0.00136	0.0265	CbGeAlD
Vinblastine—ABCC6—cardiovascular system—atherosclerosis	0.00134	0.0262	CbGeAlD
Vinblastine—Deafness—Pravastatin—atherosclerosis	0.00131	0.0142	CcSEcCtD
Vinblastine—TUBA1A—connective tissue—atherosclerosis	0.00131	0.0255	CbGeAlD
Vinblastine—TUBB6—Pimozide—Ezetimibe—atherosclerosis	0.0013	0.288	CbGdCrCtD
Vinblastine—JUN—connective tissue—atherosclerosis	0.00129	0.0253	CbGeAlD
Vinblastine—Depression—Rosuvastatin—atherosclerosis	0.00126	0.0136	CcSEcCtD
Vinblastine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00124	0.0134	CcSEcCtD
Vinblastine—TUBG1—liver—atherosclerosis	0.00121	0.0237	CbGeAlD
Vinblastine—ABCC6—adipose tissue—atherosclerosis	0.00118	0.0231	CbGeAlD
Vinblastine—TUBA1A—cardiovascular system—atherosclerosis	0.00114	0.0222	CbGeAlD
Vinblastine—JUN—cardiovascular system—atherosclerosis	0.00113	0.022	CbGeAlD
Vinblastine—Pharyngitis—Rosuvastatin—atherosclerosis	0.00112	0.0122	CcSEcCtD
Vinblastine—TUBB4A—connective tissue—atherosclerosis	0.00112	0.0218	CbGeAlD
Vinblastine—TUBB6—Fluvastatin—Rosuvastatin—atherosclerosis	0.0011	0.244	CbGdCrCtD
Vinblastine—TUBB2B—connective tissue—atherosclerosis	0.00108	0.0211	CbGeAlD
Vinblastine—TUBB6—Simvastatin—Pravastatin—atherosclerosis	0.00105	0.234	CbGdCrCtD
Vinblastine—TUBB6—Simvastatin—Lovastatin—atherosclerosis	0.00105	0.234	CbGdCrCtD
Vinblastine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00105	0.0114	CcSEcCtD
Vinblastine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00103	0.0111	CcSEcCtD
Vinblastine—TUBB2A—connective tissue—atherosclerosis	0.00102	0.0198	CbGeAlD
Vinblastine—Angina pectoris—Niacin—atherosclerosis	0.001	0.0109	CcSEcCtD
Vinblastine—TUBA1A—adipose tissue—atherosclerosis	0.001	0.0196	CbGeAlD
Vinblastine—Depression—Simvastatin—atherosclerosis	0.000997	0.0108	CcSEcCtD
Vinblastine—JUN—adipose tissue—atherosclerosis	0.000993	0.0194	CbGeAlD
Vinblastine—Angina pectoris—Pravastatin—atherosclerosis	0.000988	0.0107	CcSEcCtD
Vinblastine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00098	0.0106	CcSEcCtD
Vinblastine—TUBB4A—cardiovascular system—atherosclerosis	0.000971	0.019	CbGeAlD
Vinblastine—Pharyngitis—Ezetimibe—atherosclerosis	0.000934	0.0101	CcSEcCtD
Vinblastine—Depression—Pravastatin—atherosclerosis	0.000902	0.00977	CcSEcCtD
Vinblastine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000891	0.00966	CcSEcCtD
Vinblastine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000886	0.0096	CcSEcCtD
Vinblastine—Myocardial infarction—Pravastatin—atherosclerosis	0.000886	0.0096	CcSEcCtD
Vinblastine—TUBB6—cardiovascular system—atherosclerosis	0.000872	0.017	CbGeAlD
Vinblastine—TUBB4B—connective tissue—atherosclerosis	0.000871	0.017	CbGeAlD
Vinblastine—Alopecia—Lovastatin—atherosclerosis	0.000848	0.00919	CcSEcCtD
Vinblastine—Alopecia—Ezetimibe—atherosclerosis	0.000832	0.00901	CcSEcCtD
Vinblastine—ABCC6—liver—atherosclerosis	0.000831	0.0162	CbGeAlD
Vinblastine—Haemoglobin—Niacin—atherosclerosis	0.000829	0.00898	CcSEcCtD
Vinblastine—TUBB2B—adipose tissue—atherosclerosis	0.000828	0.0162	CbGeAlD
Vinblastine—Haemorrhage—Niacin—atherosclerosis	0.000824	0.00893	CcSEcCtD
Vinblastine—Hypoaesthesia—Niacin—atherosclerosis	0.00082	0.00889	CcSEcCtD
Vinblastine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000808	0.00875	CcSEcCtD
Vinblastine—Pharyngitis—Pravastatin—atherosclerosis	0.000806	0.00873	CcSEcCtD
Vinblastine—Alopecia—Simvastatin—atherosclerosis	0.000793	0.0086	CcSEcCtD
Vinblastine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000788	0.00854	CcSEcCtD
Vinblastine—TUBB—adipose tissue—atherosclerosis	0.000783	0.0153	CbGeAlD
Vinblastine—TUBB2A—adipose tissue—atherosclerosis	0.000779	0.0152	CbGeAlD
Vinblastine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000775	0.0084	CcSEcCtD
Vinblastine—TUBB6—adipose tissue—atherosclerosis	0.000769	0.015	CbGeAlD
Vinblastine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00076	0.00824	CcSEcCtD
Vinblastine—TUBB4B—cardiovascular system—atherosclerosis	0.000758	0.0148	CbGeAlD
Vinblastine—Anaemia—Ezetimibe—atherosclerosis	0.000757	0.00821	CcSEcCtD
Vinblastine—Malaise—Lovastatin—atherosclerosis	0.000753	0.00816	CcSEcCtD
Vinblastine—Vertigo—Lovastatin—atherosclerosis	0.000751	0.00813	CcSEcCtD
Vinblastine—Leukopenia—Lovastatin—atherosclerosis	0.000748	0.0081	CcSEcCtD
Vinblastine—ABCB11—liver—atherosclerosis	0.000745	0.0146	CbGeAlD
Vinblastine—Malaise—Ezetimibe—atherosclerosis	0.000739	0.00801	CcSEcCtD
Vinblastine—Alopecia—Niacin—atherosclerosis	0.000728	0.00789	CcSEcCtD
Vinblastine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000725	0.00786	CcSEcCtD
Vinblastine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000723	0.00783	CcSEcCtD
Vinblastine—Anaemia—Simvastatin—atherosclerosis	0.000722	0.00783	CcSEcCtD
Vinblastine—Alopecia—Pravastatin—atherosclerosis	0.000717	0.00777	CcSEcCtD
Vinblastine—Hypertension—Ezetimibe—atherosclerosis	0.000708	0.00767	CcSEcCtD
Vinblastine—Malaise—Simvastatin—atherosclerosis	0.000705	0.00764	CcSEcCtD
Vinblastine—TUBA1A—liver—atherosclerosis	0.000703	0.0137	CbGeAlD
Vinblastine—Discomfort—Lovastatin—atherosclerosis	0.000703	0.00761	CcSEcCtD
Vinblastine—Vertigo—Simvastatin—atherosclerosis	0.000702	0.00761	CcSEcCtD
Vinblastine—Leukopenia—Simvastatin—atherosclerosis	0.0007	0.00758	CcSEcCtD
Vinblastine—JUN—liver—atherosclerosis	0.000696	0.0136	CbGeAlD
Vinblastine—Discomfort—Ezetimibe—atherosclerosis	0.000689	0.00747	CcSEcCtD
Vinblastine—Pain—Rosuvastatin—atherosclerosis	0.000688	0.00746	CcSEcCtD
Vinblastine—Constipation—Rosuvastatin—atherosclerosis	0.000688	0.00746	CcSEcCtD
Vinblastine—TUBB4B—adipose tissue—atherosclerosis	0.000668	0.0131	CbGeAlD
Vinblastine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000668	0.00723	CcSEcCtD
Vinblastine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000663	0.00718	CcSEcCtD
Vinblastine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000658	0.00713	CcSEcCtD
Vinblastine—Discomfort—Simvastatin—atherosclerosis	0.000657	0.00712	CcSEcCtD
Vinblastine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000656	0.0071	CcSEcCtD
Vinblastine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000655	0.0071	CcSEcCtD
Vinblastine—Anaemia—Pravastatin—atherosclerosis	0.000653	0.00708	CcSEcCtD
Vinblastine—Anorexia—Lovastatin—atherosclerosis	0.00065	0.00704	CcSEcCtD
Vinblastine—Vertigo—Niacin—atherosclerosis	0.000645	0.00699	CcSEcCtD
Vinblastine—Leukopenia—Niacin—atherosclerosis	0.000642	0.00696	CcSEcCtD
Vinblastine—Malaise—Pravastatin—atherosclerosis	0.000637	0.0069	CcSEcCtD
Vinblastine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000636	0.00689	CcSEcCtD
Vinblastine—Vertigo—Pravastatin—atherosclerosis	0.000635	0.00688	CcSEcCtD
Vinblastine—Leukopenia—Pravastatin—atherosclerosis	0.000632	0.00685	CcSEcCtD
Vinblastine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000625	0.00677	CcSEcCtD
Vinblastine—Paraesthesia—Lovastatin—atherosclerosis	0.000612	0.00663	CcSEcCtD
Vinblastine—Hypertension—Pravastatin—atherosclerosis	0.00061	0.00661	CcSEcCtD
Vinblastine—Anorexia—Simvastatin—atherosclerosis	0.000608	0.00659	CcSEcCtD
Vinblastine—TUBB4A—liver—atherosclerosis	0.000601	0.0117	CbGeAlD
Vinblastine—Paraesthesia—Ezetimibe—atherosclerosis	0.000601	0.00651	CcSEcCtD
Vinblastine—Discomfort—Pravastatin—atherosclerosis	0.000594	0.00644	CcSEcCtD
Vinblastine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000593	0.00642	CcSEcCtD
Vinblastine—Decreased appetite—Lovastatin—atherosclerosis	0.000593	0.00642	CcSEcCtD
Vinblastine—Pain—Lovastatin—atherosclerosis	0.000583	0.00632	CcSEcCtD
Vinblastine—Constipation—Lovastatin—atherosclerosis	0.000583	0.00632	CcSEcCtD
Vinblastine—Decreased appetite—Ezetimibe—atherosclerosis	0.000581	0.0063	CcSEcCtD
Vinblastine—Asthenia—Rosuvastatin—atherosclerosis	0.000577	0.00625	CcSEcCtD
Vinblastine—Paraesthesia—Simvastatin—atherosclerosis	0.000573	0.00621	CcSEcCtD
Vinblastine—Constipation—Ezetimibe—atherosclerosis	0.000572	0.0062	CcSEcCtD
Vinblastine—Pain—Ezetimibe—atherosclerosis	0.000572	0.0062	CcSEcCtD
Vinblastine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000565	0.00612	CcSEcCtD
Vinblastine—Feeling abnormal—Lovastatin—atherosclerosis	0.000562	0.00609	CcSEcCtD
Vinblastine—Anorexia—Niacin—atherosclerosis	0.000558	0.00605	CcSEcCtD
Vinblastine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000558	0.00604	CcSEcCtD
Vinblastine—Decreased appetite—Simvastatin—atherosclerosis	0.000554	0.00601	CcSEcCtD
Vinblastine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000551	0.00597	CcSEcCtD
Vinblastine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000551	0.00596	CcSEcCtD
Vinblastine—Anorexia—Pravastatin—atherosclerosis	0.00055	0.00596	CcSEcCtD
Vinblastine—TUBB—liver—atherosclerosis	0.000549	0.0107	CbGeAlD
Vinblastine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000547	0.00593	CcSEcCtD
Vinblastine—TUBB2A—liver—atherosclerosis	0.000546	0.0107	CbGeAlD
Vinblastine—Constipation—Simvastatin—atherosclerosis	0.000545	0.00591	CcSEcCtD
Vinblastine—Pain—Simvastatin—atherosclerosis	0.000545	0.00591	CcSEcCtD
Vinblastine—Abdominal pain—Lovastatin—atherosclerosis	0.000539	0.00584	CcSEcCtD
Vinblastine—TUBB6—liver—atherosclerosis	0.000539	0.0105	CbGeAlD
Vinblastine—Dizziness—Rosuvastatin—atherosclerosis	0.000532	0.00576	CcSEcCtD
Vinblastine—Abdominal pain—Ezetimibe—atherosclerosis	0.000529	0.00573	CcSEcCtD
Vinblastine—Paraesthesia—Niacin—atherosclerosis	0.000526	0.0057	CcSEcCtD
Vinblastine—Feeling abnormal—Simvastatin—atherosclerosis	0.000526	0.00569	CcSEcCtD
Vinblastine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000522	0.00565	CcSEcCtD
Vinblastine—Paraesthesia—Pravastatin—atherosclerosis	0.000518	0.00561	CcSEcCtD
Vinblastine—Decreased appetite—Niacin—atherosclerosis	0.000509	0.00552	CcSEcCtD
Vinblastine—Abdominal pain—Simvastatin—atherosclerosis	0.000504	0.00546	CcSEcCtD
Vinblastine—Headache—Rosuvastatin—atherosclerosis	0.000504	0.00546	CcSEcCtD
Vinblastine—Hypersensitivity—Lovastatin—atherosclerosis	0.000502	0.00544	CcSEcCtD
Vinblastine—Decreased appetite—Pravastatin—atherosclerosis	0.000501	0.00543	CcSEcCtD
Vinblastine—Pain—Niacin—atherosclerosis	0.000501	0.00543	CcSEcCtD
Vinblastine—ABCB1—blood vessel—atherosclerosis	0.000494	0.00965	CbGeAlD
Vinblastine—Pain—Pravastatin—atherosclerosis	0.000493	0.00534	CcSEcCtD
Vinblastine—Constipation—Pravastatin—atherosclerosis	0.000493	0.00534	CcSEcCtD
Vinblastine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000493	0.00534	CcSEcCtD
Vinblastine—Asthenia—Lovastatin—atherosclerosis	0.000489	0.0053	CcSEcCtD
Vinblastine—Asthenia—Ezetimibe—atherosclerosis	0.00048	0.0052	CcSEcCtD
Vinblastine—Gastrointestinal pain—Niacin—atherosclerosis	0.000479	0.00519	CcSEcCtD
Vinblastine—Nausea—Rosuvastatin—atherosclerosis	0.000478	0.00518	CcSEcCtD
Vinblastine—ABCC1—adipose tissue—atherosclerosis	0.000476	0.0093	CbGeAlD
Vinblastine—Feeling abnormal—Pravastatin—atherosclerosis	0.000475	0.00515	CcSEcCtD
Vinblastine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000472	0.00511	CcSEcCtD
Vinblastine—Hypersensitivity—Simvastatin—atherosclerosis	0.00047	0.00509	CcSEcCtD
Vinblastine—TUBB4B—liver—atherosclerosis	0.000469	0.00915	CbGeAlD
Vinblastine—Diarrhoea—Lovastatin—atherosclerosis	0.000467	0.00506	CcSEcCtD
Vinblastine—Abdominal pain—Niacin—atherosclerosis	0.000463	0.00502	CcSEcCtD
Vinblastine—Asthenia—Simvastatin—atherosclerosis	0.000458	0.00496	CcSEcCtD
Vinblastine—Diarrhoea—Ezetimibe—atherosclerosis	0.000458	0.00496	CcSEcCtD
Vinblastine—Abdominal pain—Pravastatin—atherosclerosis	0.000456	0.00494	CcSEcCtD
Vinblastine—Dizziness—Lovastatin—atherosclerosis	0.000451	0.00489	CcSEcCtD
Vinblastine—Dizziness—Ezetimibe—atherosclerosis	0.000442	0.00479	CcSEcCtD
Vinblastine—Diarrhoea—Simvastatin—atherosclerosis	0.000436	0.00473	CcSEcCtD
Vinblastine—Vomiting—Lovastatin—atherosclerosis	0.000434	0.0047	CcSEcCtD
Vinblastine—Hypersensitivity—Niacin—atherosclerosis	0.000432	0.00468	CcSEcCtD
Vinblastine—Headache—Lovastatin—atherosclerosis	0.000427	0.00463	CcSEcCtD
Vinblastine—Vomiting—Ezetimibe—atherosclerosis	0.000425	0.00461	CcSEcCtD
Vinblastine—Hypersensitivity—Pravastatin—atherosclerosis	0.000425	0.0046	CcSEcCtD
Vinblastine—Dizziness—Simvastatin—atherosclerosis	0.000422	0.00457	CcSEcCtD
Vinblastine—Asthenia—Niacin—atherosclerosis	0.00042	0.00455	CcSEcCtD
Vinblastine—Headache—Ezetimibe—atherosclerosis	0.000419	0.00454	CcSEcCtD
Vinblastine—Asthenia—Pravastatin—atherosclerosis	0.000414	0.00448	CcSEcCtD
Vinblastine—Vomiting—Simvastatin—atherosclerosis	0.000406	0.00439	CcSEcCtD
Vinblastine—Nausea—Lovastatin—atherosclerosis	0.000405	0.00439	CcSEcCtD
Vinblastine—Diarrhoea—Niacin—atherosclerosis	0.000401	0.00434	CcSEcCtD
Vinblastine—Headache—Simvastatin—atherosclerosis	0.0004	0.00433	CcSEcCtD
Vinblastine—Nausea—Ezetimibe—atherosclerosis	0.000397	0.0043	CcSEcCtD
Vinblastine—Diarrhoea—Pravastatin—atherosclerosis	0.000395	0.00427	CcSEcCtD
Vinblastine—Dizziness—Niacin—atherosclerosis	0.000387	0.0042	CcSEcCtD
Vinblastine—Dizziness—Pravastatin—atherosclerosis	0.000381	0.00413	CcSEcCtD
Vinblastine—ABCC2—liver—atherosclerosis	0.000379	0.0074	CbGeAlD
Vinblastine—Nausea—Simvastatin—atherosclerosis	0.000379	0.0041	CcSEcCtD
Vinblastine—Vomiting—Niacin—atherosclerosis	0.000372	0.00403	CcSEcCtD
Vinblastine—Headache—Niacin—atherosclerosis	0.000367	0.00398	CcSEcCtD
Vinblastine—Vomiting—Pravastatin—atherosclerosis	0.000367	0.00397	CcSEcCtD
Vinblastine—Headache—Pravastatin—atherosclerosis	0.000361	0.00391	CcSEcCtD
Vinblastine—Nausea—Niacin—atherosclerosis	0.000348	0.00377	CcSEcCtD
Vinblastine—Nausea—Pravastatin—atherosclerosis	0.000343	0.00371	CcSEcCtD
Vinblastine—ABCC1—liver—atherosclerosis	0.000334	0.00652	CbGeAlD
Vinblastine—ABCB1—cardiovascular system—atherosclerosis	0.00022	0.0043	CbGeAlD
Vinblastine—ABCB1—adipose tissue—atherosclerosis	0.000194	0.0038	CbGeAlD
Vinblastine—CYP3A4—liver—atherosclerosis	0.000193	0.00376	CbGeAlD
Vinblastine—CYP2D6—liver—atherosclerosis	0.000189	0.0037	CbGeAlD
Vinblastine—ABCB1—liver—atherosclerosis	0.000136	0.00266	CbGeAlD
Vinblastine—ABCB1—Metabolism—APOA4—atherosclerosis	1.1e-05	6.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—LPL—atherosclerosis	1.1e-05	6.98e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARA—atherosclerosis	1.09e-05	6.87e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.08e-05	6.86e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLTP—atherosclerosis	1.07e-05	6.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PRKCG—atherosclerosis	1.07e-05	6.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.07e-05	6.76e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—MAPK3—atherosclerosis	1.06e-05	6.73e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LCAT—atherosclerosis	1.06e-05	6.7e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—FABP4—atherosclerosis	1.06e-05	6.7e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AGT—atherosclerosis	1.05e-05	6.66e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SOCS3—atherosclerosis	1.05e-05	6.64e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOA4—atherosclerosis	1.04e-05	6.58e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—APOE—atherosclerosis	1.03e-05	6.52e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.02e-05	6.49e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ABCA1—atherosclerosis	1.02e-05	6.49e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.02e-05	6.47e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CAV1—atherosclerosis	1.02e-05	6.46e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—APOA1—atherosclerosis	1.02e-05	6.45e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP3—atherosclerosis	1.01e-05	6.41e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.01e-05	6.4e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—HMOX1—atherosclerosis	1.01e-05	6.39e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF2—atherosclerosis	1.01e-05	6.38e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP27A1—atherosclerosis	1e-05	6.34e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MTHFR—atherosclerosis	9.92e-06	6.28e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	9.82e-06	6.22e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	9.8e-06	6.21e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOB—atherosclerosis	9.79e-06	6.2e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOB—atherosclerosis	9.67e-06	6.12e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PDGFB—atherosclerosis	9.66e-06	6.12e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EDN1—atherosclerosis	9.63e-06	6.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL5—atherosclerosis	9.56e-06	6.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOA2—atherosclerosis	9.49e-06	6.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PLA2G2A—atherosclerosis	9.49e-06	6.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALOX5AP—atherosclerosis	9.49e-06	6.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALOX15—atherosclerosis	9.49e-06	6.01e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	9.44e-06	5.98e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GSTM1—atherosclerosis	9.4e-06	5.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ABCG5—atherosclerosis	9.38e-06	5.94e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LPL—atherosclerosis	9.35e-06	5.92e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LTA4H—atherosclerosis	9.31e-06	5.9e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCG8—atherosclerosis	9.31e-06	5.9e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3CG—atherosclerosis	9.29e-06	5.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APOE—atherosclerosis	9.24e-06	5.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—LPL—atherosclerosis	9.23e-06	5.84e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	9.15e-06	5.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CAV1—atherosclerosis	9.15e-06	5.8e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—APOA1—atherosclerosis	9.13e-06	5.78e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PRKCG—atherosclerosis	9.09e-06	5.75e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LPA—atherosclerosis	9.06e-06	5.74e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—GPX1—atherosclerosis	9e-06	5.7e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PPARG—atherosclerosis	8.97e-06	5.68e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOA2—atherosclerosis	8.95e-06	5.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	8.95e-06	5.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	8.95e-06	5.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALOX15—atherosclerosis	8.95e-06	5.67e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SPP1—atherosclerosis	8.85e-06	5.61e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCG5—atherosclerosis	8.84e-06	5.6e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—INS—atherosclerosis	8.8e-06	5.57e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—HMOX1—atherosclerosis	8.79e-06	5.56e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—BGN—atherosclerosis	8.77e-06	5.55e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CD36—atherosclerosis	8.77e-06	5.55e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOA5—atherosclerosis	8.68e-06	5.5e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IFNG—atherosclerosis	8.66e-06	5.48e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS2—atherosclerosis	8.61e-06	5.45e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LPA—atherosclerosis	8.53e-06	5.4e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOB—atherosclerosis	8.42e-06	5.33e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PLA2G1B—atherosclerosis	8.36e-06	5.29e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—atherosclerosis	8.31e-06	5.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	8.28e-06	5.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—BGN—atherosclerosis	8.27e-06	5.23e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PDGFB—atherosclerosis	8.19e-06	5.19e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—atherosclerosis	8.19e-06	5.18e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOA5—atherosclerosis	8.18e-06	5.18e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARA—atherosclerosis	8.15e-06	5.16e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALOX5—atherosclerosis	8.07e-06	5.11e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—atherosclerosis	8.07e-06	5.11e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—LPL—atherosclerosis	8.04e-06	5.09e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AGT—atherosclerosis	8e-06	5.06e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AGT—atherosclerosis	7.9e-06	5e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—INS—atherosclerosis	7.89e-06	5e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	7.88e-06	4.99e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GPX1—atherosclerosis	7.84e-06	4.97e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOE—atherosclerosis	7.83e-06	4.96e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LEP—atherosclerosis	7.83e-06	4.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	7.77e-06	4.92e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—atherosclerosis	7.77e-06	4.92e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CAV1—atherosclerosis	7.76e-06	4.92e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOA1—atherosclerosis	7.74e-06	4.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOE—atherosclerosis	7.74e-06	4.9e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL1B—atherosclerosis	7.72e-06	4.89e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NOS3—atherosclerosis	7.72e-06	4.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CAV1—atherosclerosis	7.67e-06	4.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOA1—atherosclerosis	7.65e-06	4.84e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CD36—atherosclerosis	7.64e-06	4.84e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALOX5—atherosclerosis	7.61e-06	4.82e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—ESR1—atherosclerosis	7.48e-06	4.74e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—F2—atherosclerosis	7.39e-06	4.68e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.36e-06	4.66e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SERPINE1—atherosclerosis	7.25e-06	4.59e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAMPT—atherosclerosis	7.24e-06	4.58e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—atherosclerosis	7.24e-06	4.58e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFKB1—atherosclerosis	7.21e-06	4.56e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LIPC—atherosclerosis	7.2e-06	4.56e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—atherosclerosis	7.16e-06	4.54e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOC3—atherosclerosis	7.15e-06	4.53e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LDLR—atherosclerosis	7.11e-06	4.5e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARA—atherosclerosis	7.1e-06	4.5e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK8—atherosclerosis	7.08e-06	4.49e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3CG—atherosclerosis	7.07e-06	4.48e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—atherosclerosis	7.06e-06	4.47e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3CG—atherosclerosis	6.98e-06	4.42e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CETP—atherosclerosis	6.94e-06	4.4e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LCAT—atherosclerosis	6.92e-06	4.38e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—FABP4—atherosclerosis	6.92e-06	4.38e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS3—atherosclerosis	6.92e-06	4.38e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AGT—atherosclerosis	6.88e-06	4.35e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAMPT—atherosclerosis	6.82e-06	4.32e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	6.82e-06	4.32e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOA4—atherosclerosis	6.8e-06	4.3e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LIPC—atherosclerosis	6.78e-06	4.29e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—atherosclerosis	6.74e-06	4.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOC3—atherosclerosis	6.74e-06	4.27e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOE—atherosclerosis	6.74e-06	4.27e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LDLR—atherosclerosis	6.7e-06	4.24e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—INS—atherosclerosis	6.69e-06	4.24e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.68e-06	4.23e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CAV1—atherosclerosis	6.67e-06	4.23e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOA1—atherosclerosis	6.66e-06	4.22e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SCARB1—atherosclerosis	6.65e-06	4.21e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—INS—atherosclerosis	6.61e-06	4.18e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL2—atherosclerosis	6.58e-06	4.17e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CETP—atherosclerosis	6.54e-06	4.14e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—STAT3—atherosclerosis	6.48e-06	4.1e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—atherosclerosis	6.47e-06	4.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—atherosclerosis	6.33e-06	4.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HMGCR—atherosclerosis	6.28e-06	3.98e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SCARB1—atherosclerosis	6.26e-06	3.97e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—MAPK3—atherosclerosis	6.19e-06	3.92e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.17e-06	3.91e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.15e-06	3.9e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SERPINE1—atherosclerosis	6.15e-06	3.89e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	6.08e-06	3.85e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—atherosclerosis	6.06e-06	3.84e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.92e-06	3.75e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOS3—atherosclerosis	5.87e-06	3.72e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—atherosclerosis	5.87e-06	3.72e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.85e-06	3.7e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.85e-06	3.7e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOA2—atherosclerosis	5.85e-06	3.7e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.85e-06	3.7e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NOS3—atherosclerosis	5.8e-06	3.67e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.78e-06	3.66e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—INS—atherosclerosis	5.76e-06	3.64e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ABCA1—atherosclerosis	5.6e-06	3.54e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LPA—atherosclerosis	5.58e-06	3.53e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—BGN—atherosclerosis	5.4e-06	3.42e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOA5—atherosclerosis	5.35e-06	3.39e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—atherosclerosis	5.3e-06	3.36e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—atherosclerosis	5.28e-06	3.34e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ABCA1—atherosclerosis	5.27e-06	3.34e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CXCL8—atherosclerosis	5.21e-06	3.3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.15e-06	3.26e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NOS3—atherosclerosis	5.05e-06	3.2e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.97e-06	3.15e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—STAT3—atherosclerosis	4.94e-06	3.13e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HMOX1—atherosclerosis	4.8e-06	3.04e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—MAPK3—atherosclerosis	4.72e-06	2.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—atherosclerosis	4.71e-06	2.98e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKB1—atherosclerosis	4.66e-06	2.95e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—atherosclerosis	4.62e-06	2.92e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOB—atherosclerosis	4.6e-06	2.91e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK8—atherosclerosis	4.58e-06	2.9e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—atherosclerosis	4.58e-06	2.9e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HMOX1—atherosclerosis	4.52e-06	2.86e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—atherosclerosis	4.52e-06	2.86e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—atherosclerosis	4.47e-06	2.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.46e-06	2.82e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LIPC—atherosclerosis	4.43e-06	2.81e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOC3—atherosclerosis	4.41e-06	2.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LPL—atherosclerosis	4.39e-06	2.78e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LDLR—atherosclerosis	4.38e-06	2.77e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOB—atherosclerosis	4.33e-06	2.74e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPX1—atherosclerosis	4.28e-06	2.71e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CETP—atherosclerosis	4.28e-06	2.71e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—atherosclerosis	4.23e-06	2.68e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.22e-06	2.67e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—STAT3—atherosclerosis	4.19e-06	2.65e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—atherosclerosis	4.17e-06	2.64e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CD36—atherosclerosis	4.17e-06	2.64e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LPL—atherosclerosis	4.14e-06	2.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.1e-06	2.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPX1—atherosclerosis	4.04e-06	2.56e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MAPK3—atherosclerosis	4e-06	2.53e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—atherosclerosis	3.95e-06	2.5e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CD36—atherosclerosis	3.93e-06	2.49e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—atherosclerosis	3.88e-06	2.46e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARA—atherosclerosis	3.88e-06	2.46e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.87e-06	2.45e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AGT—atherosclerosis	3.76e-06	2.38e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.73e-06	2.36e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOE—atherosclerosis	3.68e-06	2.33e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARA—atherosclerosis	3.65e-06	2.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CAV1—atherosclerosis	3.65e-06	2.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOA1—atherosclerosis	3.64e-06	2.3e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—atherosclerosis	3.55e-06	2.25e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AGT—atherosclerosis	3.54e-06	2.24e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOE—atherosclerosis	3.47e-06	2.2e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—atherosclerosis	3.45e-06	2.18e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.45e-06	2.18e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.44e-06	2.18e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.43e-06	2.17e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.32e-06	2.1e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—atherosclerosis	3.21e-06	2.03e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—atherosclerosis	3.18e-06	2.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—INS—atherosclerosis	3.14e-06	1.99e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.13e-06	1.98e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.02e-06	1.91e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—INS—atherosclerosis	2.96e-06	1.88e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.96e-06	1.87e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—atherosclerosis	2.92e-06	1.85e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—atherosclerosis	2.88e-06	1.83e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOB—atherosclerosis	2.83e-06	1.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NOS3—atherosclerosis	2.76e-06	1.75e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.76e-06	1.75e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—atherosclerosis	2.72e-06	1.72e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LPL—atherosclerosis	2.71e-06	1.71e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—atherosclerosis	2.7e-06	1.71e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—atherosclerosis	2.66e-06	1.69e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPX1—atherosclerosis	2.64e-06	1.67e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.6e-06	1.65e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CD36—atherosclerosis	2.57e-06	1.63e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.52e-06	1.6e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.44e-06	1.54e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARA—atherosclerosis	2.39e-06	1.51e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.38e-06	1.5e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—atherosclerosis	2.32e-06	1.47e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AGT—atherosclerosis	2.31e-06	1.47e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOE—atherosclerosis	2.27e-06	1.44e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.25e-06	1.42e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.24e-06	1.42e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.05e-06	1.3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.98e-06	1.25e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—INS—atherosclerosis	1.94e-06	1.23e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—atherosclerosis	1.78e-06	1.12e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NOS3—atherosclerosis	1.7e-06	1.08e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.55e-06	9.84e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—atherosclerosis	1.27e-06	8.03e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.19e-06	7.56e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—atherosclerosis	7.81e-07	4.94e-06	CbGpPWpGaD
